In patients meeting the EFNS/PNS criteria for definite CIDP, the frequency of antibodies to Caspr1 and CNTN1 complex was 1.9% in a Barcelona, Spain, cohort and 4.3% in a German cohort of acute-onset CIDP. Here, CNTN1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.